INSIGHTS ON DRUG DEVELOPMENT
-
Application Of LC-UV/MS Workflows To Increase Efficiency
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
UPLC-MS/MS Determination Of GLP-1 Analogue
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Robust Database Characterizes And Optimizes Product Development
Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and deārisk innovative programs through early dialogue.
-
How To Reduce Batch Loss In Biopharma Production12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
What Will It Take To Make MCED And MRD A Reality?6/30/2026
Cancer mortality is declining, but the need for earlier action remains. Gain insight into how MCED and MRD are advancing cancer detection and surveillance, helping clinicians identify disease sooner.
-
Enabling Quality By Design9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing3/20/2026
Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.
-
Little Patients, Big Challenges: Developing Pediatric Formulations5/12/2025
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
DRUG DEVELOPMENT SOLUTIONS
-
OSDPredict™ uses artificial intelligence and machine learning to help sponsors proactively identify and address formulation challenges early — before they can disrupt downstream development.
-
GO BEYOND with the SCIEX 7500 system, high performance triple quadrupole LC-MS/MS mass spectrometer
Enter a new era of sensitivity and LC-MS/MS innovation with the SCIEX 7500 system. GO BEYOND current limits of sensitivity, productivity targets, ruggedness and robustness challenges. Pioneer new discoveries with this innovation.
-
Learn how an innovative development platform with the unique ability to fully integrate DDI studies accelerate timelines and improve the likelihood of downstream success.
-
Learn about a solution for next-generation in vitro models that leverages cutting-edge organ-on-a-chip technology to emulate human biology with unparalleled accuracy compared to conventional models.
-
We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.